Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: Results from CALGB 9342

Authors

Lyndsay N. Harris, Dana-Farber Cancer Institute
Gloria Broadwater, Duke University
Nancy U. Lin, Dana-Farber Cancer Institute
Alexander Miron, Dana-Farber Cancer Institute
Stuart J. Schnitt, Beth Israel Deaconess Medical Center
David Cowan, University of North Carolina at Chapel Hill
Jonathan Lara, St. Barnabas Medical Center
Ira Bleiweiss, Mount Sinai School of Medicine
Donald Berry, MD Anderson Cancer Center
Matthew Ellis, Washington University School of Medicine in St. LouisFollow
Daniel F. Hayes, University of Michigan - Ann Arbor
Eric P. Winer, Dana-Farber Cancer Institute
Lynn Dressler, University of North Carolina at Chapel Hill

Journal

Breast Cancer Research

Publication Date

2006

Volume

8

Inclusive Pages

R66

Document Type

Open Access Publication

Rights and Permissions

Breast Cancer Research 2006, 8:R66 http://breast-cancer-research.com/content/8/6/R66 © 2006 Harris et al.; licensee BioMed Central Ltd.

Recommended Citation

Harris, Lyndsay N.; Broadwater, Gloria; Lin, Nancy U.; Miron, Alexander; Schnitt, Stuart J.; Cowan, David; Lara, Jonathan; Bleiweiss, Ira; Berry, Donald; Ellis, Matthew; Hayes, Daniel F.; Winer, Eric P.; and Dressler, Lynn, "Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: Results from CALGB 9342." Breast Cancer Research. 8, R66. (2006).
https://digitalcommons.wustl.edu/open_access_pubs/189